Does feticide shorten termination duration in second trimester pregnancy terminations?

Backround: A retrospective (case-controlled) study was conducted with the aim of identifying the effect of the use of misoprostol on termination time in patients who did and did not undergo feticide procedures in second trimester pregnancy terminations. Methods: The sampling of the study consisted of 144 pregnant women who were diagnosed as having major fetal anomalies incompatible with life, and were recommended for termination of pregnancy. The investigation showed that feticide procedures were performed for 99 women, and feticide procedures were not performed for 45 women. Misoprostol protocol was administered for 48 hours in the termination period; whether the feticide procedure directly affected the termination duration in patients who did and did not undergo feticide was evaluated. Results: Abortion/birth was achieved in 103 (71.5%) women during the first 48 hours. There was no significant difference between the termination duration of the misoprostol protocol among the women who did and did not undergo feticide. There was no significant difference between the termination durations and fetal biometric measurements (BPD, HC) except head diameters (p=0.020 and p=0.015). Conclusions: The misoprostol protocol is shown to be effective and safe for the termination of pregnancies during the second trimester. Feticide has no affect on the duration of termination. DOI: https://dx.doi.org/10.4314/ahs.v19i1.28 Cite as: \u15e\u131k A, Bilecan S, Kumbasar S, Akpak YK, YA A. Does feticide shorten termination duration in second trimester pregnancy terminations? Afri Health Sci. 2019;19(1). 1544-1553. https://dx.doi.org/10.4314/ahs.v19i1.2

Urinary symptoms and incontinence in postmenopausal women and the effects on quality of life

This study was conducted to determine the effects of urinary symptoms and incontinence on quality of life in postmenopausal women. The sample of the cross-sectional study consisted of 327 women aged 50-65 who visited primary healthcare centers between 16 April and 30 July 2018. The data were collected using a personal information form, the Urinary Symptom Profile Questionnaire (USP) and the Incontinence Quality of Life Scale (I-QOL). The mean age of the women participating in the study was 57.89 +/- 5.05. It was found that 50.5% of the women had a history of incontinence. While the total mean USP score of all women participating in the study was 4.94 +/- 4.81, it was 7.98 +/- 4.85 for the women with a history of incontinence. The mean total I-QOL score was 87.09 +/- 16.04 in all women and 76.95 +/- 16.93 in the women with a history of incontinence. The women with a history of incontinence were found to have a strong negative correlation between their total USP and total I-QOL scores. In this study, it was found that the quality of life of women with urinary incontinence, especially their psychosocial health, was found to be significantly affected